Patient-Reported Experiences on Adalimumab Biosimilar SB5 and Correlation With ...

Retrieved on: 2024-02-03 18:12:34

Tags for this article:

Autoimmune diseases

Abdominal pain

Diarrhea

Monoclonal antibodies

Immunosuppressants

Ulcerative colitis

Inflammatory bowel disease

Click the tags to see associated articles and topics

Patient-Reported Experiences on Adalimumab Biosimilar SB5 and Correlation With .... View article details on HISWAI: https://www.centerforbiosimilars.com/view/patient-reported-experiences-on-adalimumab-biosimilar-sb5-and-correlation-with-treatment-persistence

Excerpt

Additionally, the FDA accepted a biologic license application for DMB-3115, an ustekinumab biosimilar developed by Accord Biopharma. If successful ...

Article found on: www.centerforbiosimilars.com

View Original Article